[Improving the technology for obtaining an ingredient with probiotic properties using a new complex proteolytic enzyme preparation].

Q2 Medicine
Voprosy pitaniia Pub Date : 2024-01-01 Epub Date: 2024-09-16 DOI:10.33029/0042-8833-2024-93-5-142-152
E V Kuksova, E V Kostyleva, A S Sereda, A A Toloknova, E A Fursova, G S Volkova
{"title":"[Improving the technology for obtaining an ingredient with probiotic properties using a new complex proteolytic enzyme preparation].","authors":"E V Kuksova, E V Kostyleva, A S Sereda, A A Toloknova, E A Fursova, G S Volkova","doi":"10.33029/0042-8833-2024-93-5-142-152","DOIUrl":null,"url":null,"abstract":"<p><p>The development of technologies for producing bacterial concentrates and enzyme preparations using domestic microbial strains is an urgent task. The use of whey protein hydrolysates as components of nutrient media for probiotic bacteria consortia for the cultivation of lactic acid and bifidobacteria makes it possible to improve and develop innovative processes for obtaining bacterial concentrates with the required functional properties for the production of dietary supplements. A consortium of probiotic microorganisms (lactic acid and bifidobacteria) was created in the All-Russian Scientific Research Institute of Food Biotechnology as a starter culture for specialized dairy products. Using strain Aspergillus oryzae 21-154 LAP a new complex enzyme preparation with a laboratory name Protoorizin LAP has been obtained providing the extensive hydrolysis of protein substrates. <b>The purpose</b> of the research was to evaluate the possibility of using the new domestic proteolytic enzyme preparation Protoorizin LAP in preparing whey-based nutrient media for culturing a consortium of probiotic microorganisms to obtain bacterial concentrates. <b>Material and methods</b>. The object of the research was a symbiotic consortium, including lactic acid bacteria strains (Lactobacillus delbrueckii ssp. bulgaricus Д-16, Lactobacillus plantarum 578/25, Lactobacillus helveticus 842(D)-2, Lactococcus lactis subsp. lactis М-12, Streptococcus thermophilus В-92) and bifidobacteria (Bifidobacterium longum Б-2). Unclarified curd whey and whey protein concentrate were taken as the nutrient medium basis. The media were treated with β-galactosidase to reduce the lactose content. In order to hydrolyze proteins, the control culture medium was treated with commercial preparations: serine protease - Alcalase® 2.4 L and leucine aminopeptidase - Flavourzyme® 1000 L. In the experimental medium, two imported preparations were replaced with a laboratory sample of the enzyme preparation Protoorizin LAP. In the prepared nutrient media, the content of amine nitrogen, free amino acids and soluble protein was determined, and electrophoretic analysis of proteins and peptides was carried out. The consortium growth was monitored by the content of dry substances and reducing sugars, by active and titratable acidity, as well as by microscopy. The number of viable cells of lactic acid bacteria and bifidobacteria at the end of fermentation and in the resulting bacterial concentrates were determined by sieving on the appropriate selective agar media using an automatic colony counter. <b>Results</b>. The effectiveness of Protoorizin LAP in the hydrolysis of whey proteins significantly exceeded the result of the combined action of Alcalase® 2.4 L and Flavourzyme® 1000 L both in terms of reducing the undigested protein content, including immunogenic fractions, and in terms of the yield of soluble protein, amine nitrogen and amino acids. The nutrient media obtained using proteases ensured good growth and development of the probiotic consortium. Due to the high content of free amino acids, the dynamics of carbohydrate consumption, titratable acidity, and the number of viable cells were higher in the medium obtained using Protoorizin LAP than when using commercial preparations. At the same time, a high titer of probiotic strains and good cultural and morphological characteristics were obtained on all media. The experimental preparation Protoorizin LAP provided the increase in viability of bacterial cells after lyophilization. <b>Conclusion</b>. The technological method that include application of the new proteolytic preparation Protoorizin LAP in preparing nutrient media based on whey proteins was developed. The method can be used in the technology of producing bacterial concentrates at the stage of culturing of the created lactic acid and bifidobacteria consortium. The bacterial concentrate can be recommended as a recipe ingredient in the manufacture of dietary supplements or foods for special dietary uses containing probiotics.</p>","PeriodicalId":23652,"journal":{"name":"Voprosy pitaniia","volume":"93 5","pages":"142-152"},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Voprosy pitaniia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33029/0042-8833-2024-93-5-142-152","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/9/16 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

The development of technologies for producing bacterial concentrates and enzyme preparations using domestic microbial strains is an urgent task. The use of whey protein hydrolysates as components of nutrient media for probiotic bacteria consortia for the cultivation of lactic acid and bifidobacteria makes it possible to improve and develop innovative processes for obtaining bacterial concentrates with the required functional properties for the production of dietary supplements. A consortium of probiotic microorganisms (lactic acid and bifidobacteria) was created in the All-Russian Scientific Research Institute of Food Biotechnology as a starter culture for specialized dairy products. Using strain Aspergillus oryzae 21-154 LAP a new complex enzyme preparation with a laboratory name Protoorizin LAP has been obtained providing the extensive hydrolysis of protein substrates. The purpose of the research was to evaluate the possibility of using the new domestic proteolytic enzyme preparation Protoorizin LAP in preparing whey-based nutrient media for culturing a consortium of probiotic microorganisms to obtain bacterial concentrates. Material and methods. The object of the research was a symbiotic consortium, including lactic acid bacteria strains (Lactobacillus delbrueckii ssp. bulgaricus Д-16, Lactobacillus plantarum 578/25, Lactobacillus helveticus 842(D)-2, Lactococcus lactis subsp. lactis М-12, Streptococcus thermophilus В-92) and bifidobacteria (Bifidobacterium longum Б-2). Unclarified curd whey and whey protein concentrate were taken as the nutrient medium basis. The media were treated with β-galactosidase to reduce the lactose content. In order to hydrolyze proteins, the control culture medium was treated with commercial preparations: serine protease - Alcalase® 2.4 L and leucine aminopeptidase - Flavourzyme® 1000 L. In the experimental medium, two imported preparations were replaced with a laboratory sample of the enzyme preparation Protoorizin LAP. In the prepared nutrient media, the content of amine nitrogen, free amino acids and soluble protein was determined, and electrophoretic analysis of proteins and peptides was carried out. The consortium growth was monitored by the content of dry substances and reducing sugars, by active and titratable acidity, as well as by microscopy. The number of viable cells of lactic acid bacteria and bifidobacteria at the end of fermentation and in the resulting bacterial concentrates were determined by sieving on the appropriate selective agar media using an automatic colony counter. Results. The effectiveness of Protoorizin LAP in the hydrolysis of whey proteins significantly exceeded the result of the combined action of Alcalase® 2.4 L and Flavourzyme® 1000 L both in terms of reducing the undigested protein content, including immunogenic fractions, and in terms of the yield of soluble protein, amine nitrogen and amino acids. The nutrient media obtained using proteases ensured good growth and development of the probiotic consortium. Due to the high content of free amino acids, the dynamics of carbohydrate consumption, titratable acidity, and the number of viable cells were higher in the medium obtained using Protoorizin LAP than when using commercial preparations. At the same time, a high titer of probiotic strains and good cultural and morphological characteristics were obtained on all media. The experimental preparation Protoorizin LAP provided the increase in viability of bacterial cells after lyophilization. Conclusion. The technological method that include application of the new proteolytic preparation Protoorizin LAP in preparing nutrient media based on whey proteins was developed. The method can be used in the technology of producing bacterial concentrates at the stage of culturing of the created lactic acid and bifidobacteria consortium. The bacterial concentrate can be recommended as a recipe ingredient in the manufacture of dietary supplements or foods for special dietary uses containing probiotics.

[利用新型复合蛋白水解酶制剂改进获得具有益生菌特性的配料的技术]。
开发使用国产微生物菌株生产细菌浓缩物和酶制剂的技术是一项紧迫任务。使用乳清蛋白水解物作为益生菌联合体培养乳酸菌和双歧杆菌的营养介质成分,可以改进和开发创新工艺,获得具有生产膳食补充剂所需功能特性的细菌浓缩物。全俄食品生物技术科学研究所(All-Russian Scientific Research Institute of Food Biotechnology)创建了一个益生微生物(乳酸菌和双歧杆菌)联合体,作为专用乳制品的启动培养基。通过使用菌株 Aspergillus oryzae 21-154 LAP,获得了一种新的复合酶制剂(实验室名称为 Protoorizin LAP),可广泛水解蛋白质底物。该研究的目的是评估在制备基于乳清的营养培养基时,使用新的国产蛋白水解酶制剂 Protoorizin LAP 培养益生微生物以获得细菌浓缩物的可能性。材料和方法研究对象是一个共生联合体,包括乳酸菌株(Lactobacillus delbrueckii ssp.保加利亚乳杆菌 Д-16、植物乳杆菌 578/25、螺旋乳杆菌 842(D)-2、乳酸乳球菌亚种 М-12、嗜热链球菌 В-92)和双歧杆菌(长双歧杆菌 Б-2)。营养培养基以未澄清的凝乳乳清和浓缩乳清蛋白为基础。培养基经 β-半乳糖苷酶处理,以降低乳糖含量。为了水解蛋白质,对照培养基用商品制剂处理:丝氨酸蛋白酶 - Alcalase® 2.4 L 和亮氨酸氨肽酶 - Flavourzyme® 1000 L。在制备的营养培养基中,测定了胺氮、游离氨基酸和可溶性蛋白质的含量,并对蛋白质和肽进行了电泳分析。通过干物质和还原糖的含量、活性酸度和可滴定酸度以及显微镜监测菌群的生长。使用自动菌落计数器在适当的选择性琼脂培养基上进行筛分,测定发酵结束时乳酸菌和双歧杆菌的存活细胞数以及由此产生的细菌浓缩物中的存活细胞数。结果Protoorizin LAP 在水解乳清蛋白方面的效果明显优于 Alcalase® 2.4 L 和 Flavourzyme® 1000 L 的联合作用,无论是在减少未消化蛋白质含量(包括免疫原性部分)方面,还是在可溶性蛋白质、胺氮和氨基酸的产量方面。使用蛋白酶获得的营养培养基确保了益生菌群的良好生长和发育。由于游离氨基酸含量高,使用 Protoorizin LAP 获得的培养基中的碳水化合物消耗量、可滴定酸度和存活细胞数都高于使用商业制剂获得的培养基。同时,在所有培养基上都能获得高滴度的益生菌菌株以及良好的培养和形态特征。实验制剂 Protoorizin LAP 提高了冻干后细菌细胞的活力。结论在制备基于乳清蛋白的营养培养基时,开发了一种技术方法,其中包括应用新的蛋白水解制剂 Protoorizin LAP。该方法可用于在培养乳酸菌和双歧杆菌联合体阶段生产细菌浓缩物的技术中。这种浓缩细菌可作为配方成分,用于生产含有益生菌的膳食补充剂或特殊膳食食品。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Voprosy pitaniia
Voprosy pitaniia Medicine-Medicine (all)
CiteScore
2.00
自引率
0.00%
发文量
46
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信